Asgn (ASGN) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Asgn (ASGN) over the last 16 years, with Q3 2025 value amounting to $126.5 million.
- Asgn's Cash & Equivalents fell 2406.96% to $126.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.5 million, marking a year-over-year decrease of 2406.96%. This contributed to the annual value of $205.2 million for FY2024, which is 1665.72% up from last year.
- Per Asgn's latest filing, its Cash & Equivalents stood at $126.5 million for Q3 2025, which was down 2406.96% from $138.9 million recorded in Q2 2025.
- Asgn's 5-year Cash & Equivalents high stood at $679.4 million for Q3 2021, and its period low was $65.0 million during Q1 2023.
- For the 5-year period, Asgn's Cash & Equivalents averaged around $250.6 million, with its median value being $166.6 million (2024).
- Per our database at Business Quant, Asgn's Cash & Equivalents soared by 50390.62% in 2021 and then plummeted by 8706.21% in 2023.
- Asgn's Cash & Equivalents (Quarter) stood at $529.6 million in 2021, then crashed by 86.73% to $70.3 million in 2022, then surged by 150.21% to $175.9 million in 2023, then rose by 16.66% to $205.2 million in 2024, then tumbled by 38.35% to $126.5 million in 2025.
- Its Cash & Equivalents stands at $126.5 million for Q3 2025, versus $138.9 million for Q2 2025 and $107.0 million for Q1 2025.